Pharmafile Logo
Pharmafocus logo
Advanced Search

HUTCHMED completes enrolment in phase 3 trial for lung cancer

August 21, 2025
Research and Development HUTCHMED, Oncology, clinical trial, lung cancer, non-small cell lung cancer

HUTCHMED has completed patient enrolment for the SANOVO phase 3 clinical trial, investigating the use of ORPATHYS (savolitinib) in combination …

News

Christopher Conway joins BioDuro board to strengthen global leadership

August 21, 2025
Contract Manufacturing, Manufacturing and Production Bio X Cell, BioDuro, Corporate, board of directors, contract research development and manufacturing organisation

BioDuro has announced the appointment of Christopher Conway, CEO of Bio X Cell, to its board of directors, effective immediately. …

Appointment

BioMed X and Novo Nordisk partner on oral peptide drug delivery innovation

August 19, 2025
Mergers and Acquisitions, Research and Development BioMed X, Novo Nordisk, Pharmacy, drug development, therapeutic peptides

BioMed X has announced a new collaboration with Novo Nordisk to improve oral delivery of therapeutic peptides – a major …

News
partnership

IQVIA and Veeva agree long-term partnerships to support service delivery

August 19, 2025
Mergers and Acquisitions Corporate, IQVIA, Veeva Systems

IQVIA and Veeva Systems have announced the formation of global partnerships covering clinical and commercial services. IQVIA provides advanced analytics, …

News
Lung cancer cells

Graphene-based biosensor to support new lung cancer screening test

August 18, 2025
Business Services, Research and Development Ease Healthcare, Hawkeye Bio, HydroGraph, Oncology, lung cancer

HydroGraph, a Canadian producer of ultra-pure graphene, has announced a partnership with Hawkeye Bio and Ease Healthcare to support the …

News
money-2180330_960_720

Anocca secures £32m to advance pancreatic cancer trial

August 18, 2025
Research and Development Anocca, Oncology, Pancreatic cancer, research funding

Swedish biopharma Anocca has raised approximately £32m (SEK 440m) to support the early-stage clinical development of VIDAR-1, its lead TCR-T …

News
brain_anatomy_medical_head_skull_digital_3_d_x_ray_xray_psychedelic_3720x2631

FDA decision on Neurizon’s ALS therapy delayed until October

August 18, 2025
Medical Communications Coya Therapeutics, Neurizon, Neurology, US Food and Drug Administration, amyotrophic lateral sclerosis

Neurizon Therapeutics has announced that the US Food and Drug Administration (FDA) will delay its decision on the company’s Clinical …

News

FDA approves first new fibromyalgia therapy in over 15 years

August 18, 2025
Medical Communications, Research and Development Pain, Tonix Pharmaceutical, US Food and Drug Administration, chronic pain, clinical trial, fibromyalgia

The US Food and Drug Administration (FDA) has approved Tonix Pharmaceutical’s Tonmya (cyclobenzaprine hydrochloric acid) for the treatment of fibromyalgia …

News

Enzybel Pharma 2 and Deebio partner to address pancrelipase shortages

August 15, 2025
Manufacturing and Production, Mergers and Acquisitions Deebio, Enzybel Pharma 2, Gastrointestinal tract, Natix, pancrelipase

Enzybel Pharma 2, part of European distributor Natix, has formed an alliance with Chinese enzyme manufacturer Deebio to help alleviate …

News
Astra Zeneca Logo

NICE recommends Benralizumab for Rare Form of Vasculitis

August 15, 2025
Medical Communications, Research and Development AstraZeneca, Immunology, National Institute for Health and Care Excellence, vasculitis

The National Institute for Health and Care Excellence (NICE) has recommended AstraZeneca’s benralizumab (Fasenra) as an add-on treatment for adult …

News
drug-trials

Novartis candidate for Sjögren’s disease presents positive results

August 15, 2025
Research and Development Immunology, Novartis, Sjögren’s disease, US Food and Drug Administration, clinical trial

Novartis has reported positive results from two phase 3 clinical trials – NEPTUNUS-1 and NEPTUNUS-2 – evaluating ianalumab in adults …

News

KIFFIK Biomedical expands leadership team with two executive appointments

August 14, 2025
Research and Development Chief Investment Officer, Corporate, Diagnostics, KIFFIK Biomedical, chief scientific officer

KIFFIK Biomedical has strengthened its leadership team with the appointments of Rene Veloso as chief investment officer and Reginald Swift …

Appointment

Sanofi’s treatment granted orphan designation for rare chronic inflammatory condition

August 14, 2025
Medical Communications, Research and Development European Alliance of Associations for Rheumatology, European Medicines Agency, IgG4-related disease, Rheumatology, Sanofi

The European Medicines Agency has granted orphan designation to Sanofi’s investigational Bruton’s tyrosine kinase (BTK) inhibitor, rilzabrutinib, for the treatment …

News
Patients image

PhotoPharmics expands Parkinson’s Trial into further US states

August 14, 2025
Research and Development Neurology, PhotoPharmics, clinical trial, neurodegenerative disorders

US-based PhotoPharmics, has expanded enrollment in its Light for PD clinical trial beyond its original 300 participants, opening new sites …

News

Medidata appoints Lisa Moneymaker as chief strategy officer

August 13, 2025
Clinical Trial Services, Research and Development Corporate, Medidata, chief strategy officer

Medidata has appointed Lisa Moneymaker as chief strategy officer to support the company’s long-term growth in the life sciences technology …

Appointment

Sandoz signs renewable energy deal to supply 90% of European operations

August 13, 2025
Mergers and Acquisitions Corporate, Elawan Energy, Sandoz, decarbonisation, renewable energy

Sandoz has entered into a ten-year virtual Power Purchase Agreement with Elawan Energy for the development of new solar projects …

News

CuraCell granted approval for trial of new therapy for metastatic cancers

August 13, 2025
Research and Development CuraCell, Immunology, clinical trial, immunotherapy, metastic cancer

Swedish immunotherapy company, CuraCell, has received approval from the Paul-Ehrlich-Institut in Germany to begin a phase 1/2a clinical trial of …

News
eye1

Eyestem secures $10m to advance cell therapy for advanced eye disease

August 13, 2025
Medical Communications, Research and Development Eyestem, Opthalmology, cell therapy, dry age-related macular degeneration, geographic atrophy

Indian cell therapy company, Eyestem Research, has raised $10m in a funding round to support development of its investigational retinal …

News

Atelerix appoints new chair and non-executive director to drive global expansion

August 13, 2025
Biotech/start-up, Sales and Marketing Atelerix, Corporate, non-executive director

UK-based biotech company, Atelerix, has appointed Sunil Shah as chair of the board and Catherine Elton as non-executive director as …

Appointment
handshake-1910702_960_720

Sartorius Stedim Biotech partners with Nanotein Technologies to develop cell therapy manufacturing

August 12, 2025
Mergers and Acquisitions Corporate, Nanotein Technologies, Sartorius Stedim Biotech, cell therapy, gene therapy

Sartorius Stedim Biotech has partnered with Nanotein Technologies to expand access to immune cell activation reagents for cell therapy manufacturing. …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026